EGRX - Eagle Pharmaceuticals EPS beats by $0.34 misses on revenue August, 10 2020 06:53 AM Eagle Pharmaceuticals Inc. Eagle Pharmaceuticals (NASDAQ:EGRX): Q2 Non-GAAP EPS of $0.57 beats by $0.34; GAAP EPS of -$0.02 beats by $0.30.More news on: Eagle Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...